scholarly article | Q13442814 |
P50 | author | Jennifer Gardy | Q18359279 |
Naveed Zafar Janjua | Q39716263 | ||
Travis Salway Hottes | Q55807402 | ||
Natasha Sarah Crowcroft | Q61100890 | ||
Yan Li | Q69032212 | ||
Nathalie Bastien | Q69032280 | ||
Hugues Charest | Q86870110 | ||
Gaston De Serres | Q86870133 | ||
Steven J Drews | Q90185362 | ||
Danuta M. Skowronski | Q111259505 | ||
Suzana Sabaiduc | Q114718265 | ||
Martin Petric | Q114718266 | ||
Anne-Luise Winter | Q114718267 | ||
Kevin Fonseca | Q114718268 | ||
P2093 | author name string | Marsha Taylor | |
Jim Dickinson | |||
P2860 | cites work | The predicted antigenicity of the haemagglutinin of the 1918 Spanish influenza pandemic suggests an avian origin. | Q30329363 |
Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. | Q30357784 | ||
Estimating influenza vaccine effectiveness using routinely collected laboratory data. | Q30382480 | ||
Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada | Q30388012 | ||
Serologic assays for influenza surveillance, diagnosis and vaccine evaluation | Q34194336 | ||
Comparative efficacy of inactivated and live attenuated influenza vaccines | Q44677378 | ||
Genetic microheterogeneity of emerging H275Y influenza virus A (H1N1) in Toronto, Ontario, Canada from the 2007-2008 respiratory season | Q45384416 | ||
Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results | Q45848424 | ||
Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season | Q46159620 | ||
Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. | Q48071872 | ||
Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. | Q50801938 | ||
Clinical Efficacy of Cell Culture–Derived and Egg‐Derived Inactivated Subunit Influenza Vaccines in Healthy Adults | Q51152487 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | influenza vaccine | Q383260 |
P304 | page(s) | 1858-1868 | |
P577 | publication date | 2012-04-09 | |
P1433 | published in | Journal of Infectious Diseases | Q4051141 |
P1476 | title | Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants | |
P478 | volume | 205 |
Q47843797 | A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season |
Q35723417 | An Assessment of the Expected Cost-Effectiveness of Quadrivalent Influenza Vaccines in Ontario, Canada Using a Static Model |
Q50065275 | Beyond Antigenic Match: Moving Toward Greater Understanding of Influenza Vaccine Effectiveness |
Q92709639 | Comparison of the immunogenicity and safety of quadrivalent and tetravalent influenza vaccines in children and adolescents |
Q37331059 | Contribution of influenza viruses to medically attended acute respiratory illnesses in children in high-income countries: a meta-analysis |
Q41732569 | Cost-effectiveness of seasonal influenza vaccination in pregnant women, health care workers and persons with underlying illnesses in Belgium. |
Q30373099 | Deaths averted by influenza vaccination in the U.S. during the seasons 2005/06 through 2013/14. |
Q35956533 | Detailed Report on 2014/15 Influenza Virus Characteristics, and Estimates on Influenza Virus Vaccine Effectiveness from Austria's Sentinel Physician Surveillance Network |
Q42228543 | Effectiveness of influenza vaccine against life-threatening RT-PCR-confirmed influenza illness in US children, 2010-2012. |
Q34451202 | Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies |
Q58722425 | Estimating Vaccine-Driven Selection in Seasonal Influenza |
Q41637608 | Expected cost effectiveness of high-dose trivalent influenza vaccine in US seniors |
Q27009478 | Fluad®-MF59®-Adjuvanted Influenza Vaccine in Older Adults |
Q30833500 | Higher vaccine effectiveness in seasons with predominant circulation of seasonal influenza A(H1N1) than in A(H3N2) seasons: test-negative case-control studies using surveillance data, Spain, 2003-2011. |
Q38408953 | Hospital-based vaccine effectiveness against influenza B lineages, Hong Kong, 2009-14. |
Q26744404 | Immunogenicity and safety of inactivated quadrivalent influenza vaccine in adults: A systematic review and meta-analysis of randomised controlled trials |
Q42242172 | Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine |
Q28469374 | Influenza Vaccine Effectiveness in the Netherlands from 2003/2004 through 2013/2014: The Importance of Circulating Influenza Virus Types and Subtypes |
Q42872289 | Influenza Vaccine Effectiveness: Mysteries, Enigmas, and a Few Clues |
Q47137946 | Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada |
Q30369475 | Influenza vaccine effectiveness assessment through sentinel virological data in three post-pandemic seasons. |
Q89041842 | Influenza vaccine failure: failure to protect or failure to understand? |
Q41934389 | Influenza vaccine use to protect healthy children: A debated topic |
Q36576966 | Influenza vaccines and vaccinations in Poland - past, present and future. |
Q38415770 | Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season |
Q87852509 | Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18 |
Q42237299 | Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network, January 2014. |
Q37011575 | Introduction of a quadrivalent influenza vaccine in Italy: a budget impact analysis |
Q35130915 | Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses |
Q34778408 | Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review |
Q35076802 | Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit |
Q39675272 | Recombinant hemagglutinin influenza vaccine provides broader spectrum protection |
Q36251600 | Seasonal influenza vaccine effectiveness among children, 2010-2012. |
Q30383722 | Seasonal influenza vaccine effectiveness estimates: Development of a parsimonious case test negative model using a causal approach |
Q35037338 | Simulation study of the effect of influenza and influenza vaccination on risk of acquiring Guillain-Barré syndrome |
Q34614814 | Surveillance and vaccine effectiveness of an influenza epidemic predominated by vaccine-mismatched influenza B/Yamagata-lineage viruses in Taiwan, 2011-12 season |
Q90692852 | The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology |
Q34194443 | The effectiveness of influenza vaccination in preventing hospitalizations in children in Hong Kong, 2009-2013. |
Q24197955 | Vaccines for preventing influenza in healthy adults |
Q56603717 | Vaccines for preventing influenza in healthy adults |
Q38803189 | Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies |
Search more.